Viking Therapeutics(VKTX) - 2025 Q4 - Annual Results

Exhibit 99.1 Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update Conference call scheduled for 4:30 p.m. ET today SAN DIEGO, February 11, 2026 -- Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the fourth quarter and year ended December 31, 2025, and provided an update on its clini ...